349 related articles for article (PubMed ID: 9825831)
21. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
[TBL] [Abstract][Full Text] [Related]
22. Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs.
Mancy A; Antignac M; Minoletti C; Dijols S; Mouries V; Duong NT; Battioni P; Dansette PM; Mansuy D
Biochemistry; 1999 Oct; 38(43):14264-70. PubMed ID: 10572000
[TBL] [Abstract][Full Text] [Related]
23. High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
Peyronneau MA; Delaforge M; Riviere R; Renaud JP; Mansuy D
Eur J Biochem; 1994 Aug; 223(3):947-56. PubMed ID: 8055971
[TBL] [Abstract][Full Text] [Related]
24. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
25. Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs.
Vaclavikova R; Soucek P; Svobodova L; Anzenbacher P; Simek P; Guengerich FP; Gut I
Drug Metab Dispos; 2004 Jun; 32(6):666-74. PubMed ID: 15155559
[TBL] [Abstract][Full Text] [Related]
26. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
28. Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes.
Kerlan V; Dreano Y; Bercovici JP; Beaune PH; Floch HH; Berthou F
Biochem Pharmacol; 1992 Nov; 44(9):1745-56. PubMed ID: 1449532
[TBL] [Abstract][Full Text] [Related]
29. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.
Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF
Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4.
Gelboin HV; Krausz KW; Goldfarb I; Buters JT; Yang SK; Gonzalez FJ; Korzekwa KR; Shou M
Biochem Pharmacol; 1995 Nov; 50(11):1841-50. PubMed ID: 8615863
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
33. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
[TBL] [Abstract][Full Text] [Related]
34. 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5.
Huang Z; Guengerich FP; Kaminsky LS
Carcinogenesis; 1998 May; 19(5):867-72. PubMed ID: 9635876
[TBL] [Abstract][Full Text] [Related]
35. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes.
Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P
Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106
[TBL] [Abstract][Full Text] [Related]
36. Mechanism-based inactivation of cytochrome P450s 1A2 and 3A4 by dihydralazine in human liver microsomes.
Masubuchi Y; Horie T
Chem Res Toxicol; 1999 Oct; 12(10):1028-32. PubMed ID: 10525281
[TBL] [Abstract][Full Text] [Related]
37. Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5.
Yamazaki H; Johnson WW; Ueng YF; Shimada T; Guengerich FP
J Biol Chem; 1996 Nov; 271(44):27438-44. PubMed ID: 8910324
[TBL] [Abstract][Full Text] [Related]
38. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
[TBL] [Abstract][Full Text] [Related]
39. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
Heyn H; White RB; Stevens JC
Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
[TBL] [Abstract][Full Text] [Related]
40. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
Chiba M; Hensleigh M; Nishime JA; Balani SK; Lin JH
Drug Metab Dispos; 1996 Mar; 24(3):307-14. PubMed ID: 8820421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
